A new, low-cost Texas Children’s Hospital vaccine gets approval for use in India | Houston Public Media
The goal is to make the vaccine available in other underserved nations across the globe to help prevent future variants of concern from forming.
Feel good story of the day: I hope this one works out. No patent burden is huge.
“Hotez said because the Corbevax vaccine is cheap, has no patents and uses traditional protein-based vaccine technology it will be easier for other countries to mass-produce and distribute it.
"It's a similar technology used to make the Hepatitis B vaccine that's been made locally and all over the world for three or four decades," he said. "It really does check all of the boxes you would want for a global health vaccine."”